Samsung to set up biopharmaceutical joint venture
Thursday, February 24, 2011 - 20:30
in Mathematics & Economics
SEOUL (Reuters) - Samsung Group, South Korea's largest conglomerate, said on Friday it planned to set up a biopharmaceutical joint venture with initial capital of 300 billion won ($264.4 million).
